LENVATINIB and ASTHENIA

Overview

ASTHENIA is the #9 most commonly reported adverse reaction for LENVATINIB, manufactured by Eisai Inc.. There are 1,534 FDA adverse event reports linking LENVATINIB to ASTHENIA. This represents approximately 2.4% of all 64,104 adverse event reports for this drug.

Patients taking LENVATINIB who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ASTHENIA1,534 of 64,104 reports

ASTHENIA is a less commonly reported adverse event for LENVATINIB, but still significant enough to appear in the safety profile.

Other Side Effects of LENVATINIB

In addition to asthenia, the following adverse reactions have been reported for LENVATINIB:

DIARRHOEA — 3,869 reports
HYPERTENSION — 3,419 reports
FATIGUE — 3,124 reports
DECREASED APPETITE — 2,970 reports
NAUSEA — 2,312 reports
MALIGNANT NEOPLASM PROGRESSION — 2,165 reports
BLOOD PRESSURE INCREASED — 2,011 reports
VOMITING — 1,880 reports
DEHYDRATION — 1,460 reports
WEIGHT DECREASED — 1,366 reports

Other Drugs Associated with ASTHENIA

The following drugs have also been linked to asthenia in FDA adverse event reports:

0XYGEN ABEMACICLIB ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN TABLET EXTENDED RELEASE ACYCLOVIR ADO TRASTUZUMAB EMTANSINE

Does LENVATINIB cause ASTHENIA?

ASTHENIA has been reported as an adverse event in 1,534 FDA reports for LENVATINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ASTHENIA with LENVATINIB?

ASTHENIA accounts for approximately 2.4% of all adverse event reports for LENVATINIB, making it a notable side effect.

What should I do if I experience ASTHENIA while taking LENVATINIB?

If you experience asthenia while taking LENVATINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.